Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Molecular Targeted Therapy

abstract

  • We report the largest retrospective cohort of patients with mChRCC treated with TT and no significant difference between AA and mTOR inhibitors was observed for TTF and OS.

authors

publication date

  • July 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ejca.2017.03.011

PubMed ID

  • 28549248

Additional Document Info

start page

  • 55

end page

  • 62

volume

  • 80